Drug intelligence / Profile preview

Cerebroprotein Hydrolysate for Injection

Development stage
Unknown
Lead developer
Shenzhen Mellow Hope Pharm Industrial
Modality
Peptides, Recombinant Proteins and Enzymes
Administration
Intravenous, Intramuscular
01

Overview

Cerebroprotein Hydrolysate for Injection is a biological extract developed and marketed by Shenzhen Mellow Hope Pharmaceutical Industrial. Derived from mammalian brain tissue, it consists of a complex mixture of low-molecular-weight peptides and amino acids. The drug is intended to support neurological recovery by promoting neuronal survival, stimulating neuroplasticity, and providing neuroprotective effects. It is primarily indicated for the treatment of craniocerebral trauma (traumatic brain injury) and various cerebrovascular diseases, including stroke and cognitive deficits. The product is administered via injection and has received regulatory approval in China, where the company is a significant exporter of biopharmaceuticals.

Other names
注射用脑蛋白水解物Brain protein hydrolysate

Beyond the preview

Go deeper on Cerebroprotein Hydrolysate for Injection.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cerebroprotein Hydrolysate for Injection.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call